Cyclic Pyranopterin Monophosphate class drugs
1 result
Nulibry (fosdenopterin hydrobromide)
(fosdenopterin hydrobromide)Sentynl Therapeutics, Inc.
Usage: NULIBRY is indicated for reducing the risk of mortality in patients with molybdenum cofactor deficiency (MoCD) Type A.